veronapharma.com (VRNA): Rentabilitas operasi

Logo perusahaan publik Verona Pharma PLC (VRNA)

The operating margin time series illustrates Verona Pharma plc (VRNA) transitioning toward scaling Ohtuvayre sales following the completion of costly research, with the metric currently standing at -25.20. A risk mitigation strategy leveraging partnerships with leading pulmonologists, combined with inelastic demand for medical care, provides the company with resilience against any economic fluctuations.

VRNA: Margin operasi Verona Pharma PLC 04.07.2022 - 18.10.2025

Verona Pharma plc (VRNA) - rincian metrik lan laporan keuangan

Pambiji fundamental perusahaan:Verona Pharma PLC, VRNA
Barang utama Verona Pharma Inc.

For Verona Pharma plc (VRNA), the success of commercializing respiratory drugs is directly determined by the cost efficiency of production in the US and UK. The operating margin, calculated as the ratio of operating income to revenue, demonstrates the share of net income from every dollar earned before accounting for financial obligations. By analyzing the operating margin chart, an investor can promptly identify hidden business degradation and avoid a value trap.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Margin operasi MENS|Ligand Pharmaceuticals - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Amneal AMRX|Tingkat bathi adhedhasar bathi operasi Perrigo Company PLC|Alvotech Biopharmaceuticals - Margin operasi|Rentabilitas kegiatan operasi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Rentabilitas operasi|anipharmaceuticals.com - Tingkat bathi operasi|Margin dodolan operasi MNKD|AMPH: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.